Betta Pharmaceuticals Co., Ltd. (SHE:300558)
68.25
+0.38 (0.56%)
Aug 15, 2025, 10:45 AM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 28.56 billion as of August 14, 2025. Its market cap has increased by 114.84% in one year.
Market Cap
28.56B
Enterprise Value
30.43B
Revenue
3.07B
Ranking
n/a
PE Ratio
69.95
Stock Price
68.25
Market Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 28.56B, an increase of 181.46%. That is a compound annual growth rate of 12.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 28.56B | 26.52% |
Dec 31, 2024 | 22.57B | 4.62% |
Dec 29, 2023 | 21.57B | 5.11% |
Dec 30, 2022 | 20.53B | -38.09% |
Dec 31, 2021 | 33.15B | -25.26% |
Dec 31, 2020 | 44.36B | 68.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 417.74B |
WuXi AppTec | 286.10B |
Shenzhen Mindray Bio-Medical Electronics | 286.01B |
Sichuan Biokin Pharmaceutical | 125.34B |
Aier Eye Hospital Group | 121.03B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.00B |
Shanghai United Imaging Healthcare | 107.46B |
Yunnan Baiyao Group Co.,Ltd | 99.92B |